About
Sedivention is a Germany-based medtech startup focused on developing a minimally invasive, one-time outpatient therapy for the treatment of obesity. Their approach utilizes a targeted cryo procedure delivered via a specially designed balloon catheter to interrupt hunger-related signals in the vagus nerve. This aims to address the underlying physiological mechanisms of obesity and enable sustained appetite reduction without surgery, implants, or ongoing medication.
Key facts
At-a-glance profile data
- Website
- sedivention.com
- Headquarters
- Germany
- Founded
- 2021
- Total funding
- $10M (Seed)
- Business model
- B2B2C
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Mar 2023 | Seed | $10M | High-Tech Gründerfonds |
Tech stack
Detected on sedivention.com, last scanned 18 Sept 2026. Run your own scan
- Frontend
- jQuery
- SEO
- All in One SEO
- CMS / Builders
- WordPress
- Video / media
- Vimeo
Frequently asked
What does Sedivention do?
The company has developed a functional prototype and plans to advance product development, conduct a first-in-human study, and prepare for regulatory and market entry.
How much funding has Sedivention raised?
Sedivention has raised a total of $10M in funding. The most recent round on record is Seed.